Tracks long-term outcomes of drug-coated balloon heart procedures in adults
Records long-term results of drug-coated balloon treatment in adults with coronary artery disease.
Plain-language title generated from the registry record
Registry title: ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
Key facts
- Where
- Homberg (Efze), GermanySee the site
Where in Germany
- Universitatsklinikum des SaarlandesHomberg (Efze), GermanyNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Emory University
- Trial code
- NCT07559903
- Record updated
- 5 October 2026
- Original description
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.Read full original descriptionShow less
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
Inclusion: All adult patients (≥ 18 years of age) undergoing PCI for de novo CAD using DCB.
Exclusion: Patients under the age of 18; PCI procedures without the utilization of DCB; PCI procedures for non de novo lesions.